Atlas Trials

Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy

Clinical trial NCT01420523 · TERMINATED

Trial details

NCT number
NCT01420523
Sponsor
ANRS, Emerging Infectious Diseases
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Human Immunodeficiency VirusLipohypertrophy
Start date
2011-12-01
Primary completion
2013-04-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.